ADMA logo

ADMA Biologics (ADMA) Depreciation And Amortization

ADMA Annual D&A

$8.33 M
+$1.22 M+17.14%

31 December 2023

ADMA Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ADMA Quarterly D&A

$1.94 M
-$107.00 K-5.23%

30 September 2024

ADMA Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ADMA TTM D&A

$8.21 M
-$152.00 K-1.82%

30 September 2024

ADMA TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ADMA Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+17.1%-7.3%+0.6%
3 y3 years+111.3%+0.2%+15.4%
5 y5 years+141.8%+0.2%+15.4%

ADMA Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+51.6%-8.2%+27.8%-2.4%+49.4%
5 y5-yearat high+155.7%-8.2%+145.9%-2.4%+153.3%
alltimeall timeat high+4475.5%-8.2%+4597.3%-2.4%>+9999.0%

ADMA Biologics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sept 2024
-
$1.94 M(-5.2%)
$8.21 M(-1.8%)
June 2024
-
$2.05 M(-3.2%)
$8.36 M(-0.6%)
Mar 2024
-
$2.11 M(+0.2%)
$8.41 M(+1.0%)
Dec 2023
$8.33 M(+17.1%)
$2.11 M(+0.8%)
$8.33 M(+2.1%)
Sept 2023
-
$2.09 M(-0.3%)
$8.16 M(+2.9%)
June 2023
-
$2.10 M(+3.2%)
$7.93 M(+4.9%)
Mar 2023
-
$2.03 M(+5.0%)
$7.56 M(+6.2%)
Dec 2022
$7.11 M(+29.4%)
$1.94 M(+4.0%)
$7.11 M(+6.2%)
Sept 2022
-
$1.86 M(+8.0%)
$6.69 M(+7.0%)
June 2022
-
$1.72 M(+8.4%)
$6.25 M(+6.8%)
Mar 2022
-
$1.59 M(+4.7%)
$5.86 M(+6.6%)
Dec 2021
$5.50 M(+39.4%)
$1.52 M(+6.8%)
$5.50 M(+5.5%)
Sept 2021
-
$1.42 M(+7.3%)
$5.21 M(+8.0%)
June 2021
-
$1.33 M(+7.8%)
$4.82 M(+10.0%)
Mar 2021
-
$1.23 M(-0.2%)
$4.38 M(+11.2%)
Dec 2020
$3.94 M(+21.0%)
$1.23 M(+19.0%)
$3.94 M(+11.4%)
Sept 2020
-
$1.04 M(+16.9%)
$3.54 M(+6.5%)
June 2020
-
$885.70 K(+12.3%)
$3.32 M(+2.5%)
Mar 2020
-
$788.80 K(-4.8%)
$3.24 M(-0.5%)
Dec 2019
$3.26 M(-5.5%)
$828.60 K(+1.3%)
$3.26 M(-2.8%)
Sept 2019
-
$818.10 K(+1.5%)
$3.35 M(-0.9%)
June 2019
-
$806.10 K(+0.1%)
$3.38 M(-1.2%)
Mar 2019
-
$805.30 K(-12.8%)
$3.42 M(-0.7%)
Dec 2018
$3.45 M
$923.90 K(+9.1%)
$3.45 M(-13.5%)
Sept 2018
-
$847.10 K(+0.1%)
$3.98 M(+0.3%)
DateAnnualQuarterlyTTM
June 2018
-
$845.90 K(+2.0%)
$3.97 M(+16.7%)
Mar 2018
-
$829.50 K(-43.2%)
$3.40 M(+26.4%)
Dec 2017
$2.69 M(+473.3%)
$1.46 M(+74.7%)
$2.69 M(+99.5%)
Sept 2017
-
$836.10 K(+201.7%)
$1.35 M(+114.0%)
June 2017
-
$277.10 K(+134.6%)
$630.40 K(+34.3%)
Mar 2017
-
$118.10 K(+0.2%)
$469.30 K(-0.1%)
Dec 2016
$469.60 K(-0.0%)
$117.90 K(+0.5%)
$469.60 K(+0.1%)
Sept 2016
-
$117.30 K(+1.1%)
$468.90 K(-0.1%)
June 2016
-
$116.00 K(-2.0%)
$469.50 K(-0.3%)
Mar 2016
-
$118.40 K(+1.0%)
$471.10 K(+0.3%)
Dec 2015
$469.80 K(+89.5%)
$117.20 K(-0.6%)
$469.80 K(+4.5%)
Sept 2015
-
$117.90 K(+0.3%)
$449.40 K(+16.5%)
June 2015
-
$117.60 K(+0.4%)
$385.70 K(+21.8%)
Mar 2015
-
$117.10 K(+21.0%)
$316.70 K(+27.8%)
Dec 2014
$247.90 K(+17.7%)
$96.80 K(+78.6%)
$247.90 K(+22.3%)
Sept 2014
-
$54.20 K(+11.5%)
$202.70 K(-0.3%)
June 2014
-
$48.60 K(+0.6%)
$203.40 K(-5.6%)
Mar 2014
-
$48.30 K(-6.4%)
$215.40 K(+2.2%)
Dec 2013
$210.60 K(+15.7%)
$51.60 K(-6.0%)
$210.70 K(+5.1%)
Sept 2013
-
$54.90 K(-9.4%)
$200.40 K(+3.1%)
June 2013
-
$60.60 K(+39.0%)
$194.40 K(+8.1%)
Mar 2013
-
$43.60 K(+5.6%)
$179.90 K(-1.2%)
Dec 2012
$182.10 K
$41.30 K(-15.5%)
$182.00 K(+29.4%)
Sept 2012
-
$48.90 K(+6.1%)
$140.70 K(+53.3%)
June 2012
-
$46.10 K(+0.9%)
$91.80 K(+100.9%)
Mar 2012
-
$45.70 K
$45.70 K

FAQ

  • What is ADMA Biologics annual depreciation & amortization?
  • What is the all time high annual D&A for ADMA Biologics?
  • What is ADMA Biologics annual D&A year-on-year change?
  • What is ADMA Biologics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for ADMA Biologics?
  • What is ADMA Biologics quarterly D&A year-on-year change?
  • What is ADMA Biologics TTM depreciation & amortization?
  • What is the all time high TTM D&A for ADMA Biologics?
  • What is ADMA Biologics TTM D&A year-on-year change?

What is ADMA Biologics annual depreciation & amortization?

The current annual D&A of ADMA is $8.33 M

What is the all time high annual D&A for ADMA Biologics?

ADMA Biologics all-time high annual depreciation & amortization is $8.33 M

What is ADMA Biologics annual D&A year-on-year change?

Over the past year, ADMA annual depreciation & amortization has changed by +$1.22 M (+17.14%)

What is ADMA Biologics quarterly depreciation & amortization?

The current quarterly D&A of ADMA is $1.94 M

What is the all time high quarterly D&A for ADMA Biologics?

ADMA Biologics all-time high quarterly depreciation & amortization is $2.11 M

What is ADMA Biologics quarterly D&A year-on-year change?

Over the past year, ADMA quarterly depreciation & amortization has changed by -$152.00 K (-7.27%)

What is ADMA Biologics TTM depreciation & amortization?

The current TTM D&A of ADMA is $8.21 M

What is the all time high TTM D&A for ADMA Biologics?

ADMA Biologics all-time high TTM depreciation & amortization is $8.41 M

What is ADMA Biologics TTM D&A year-on-year change?

Over the past year, ADMA TTM depreciation & amortization has changed by +$50.50 K (+0.62%)